Devyser Diagnostics AB Statistics
Want to see SE:DVYSR full AI Analyst Report?
Devyser Diagnostics AB (DVYSR) Stock Statistics & Valuation Metrics
Total Valuation
Devyser Diagnostics AB has a market cap or net worth of SEK 1.07B. The enterprise value is SEK 813.30M.
- Market Cap
- SEK 1.07B
- Enterprise Value
- SEK 813.30M
Share Statistics
Devyser Diagnostics AB has 16,889,807 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 16,889,807
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Devyser Diagnostics AB’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 2.57%.
- Return on Equity (ROE)
- -0.02
- Return on Assets (ROA)
- -0.02
- Return on Invested Capital (ROIC)
- 2.57%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 2.26M
- Profits Per Employee
- -75.68K
- Employee Count
- 111
- Asset Turnover
- 0.53
- Inventory Turnover
- 1.31
Valuation Ratios
The current PE Ratio of Devyser Diagnostics AB is 41.51. Devyser Diagnostics AB’s PEG ratio is 0.04.
- PE Ratio
- 41.51
- PS Ratio
- 4.20
- PB Ratio
- 2.74
- Price to FCF
- 24.61
- Price to Operating Cash Flow
- 18.34
- PEG Ratio
- 0.04
Income Statement
In the last 12 months, Devyser Diagnostics AB had revenue of 250.50M and earned -8.40M in profits. Earnings per share was -0.51.
- Revenue
- 250.50M
- Gross Profit
- 201.90M
- Operating Income
- 10.60M
- Pretax Income
- -2.60M
- Net Income
- -8.40M
- EBITDA
- 37.70M
- Earnings Per Share (EPS)
- -0.51
Cash Flow
In the last 12 months, operating cash flow was 58.10M and capital expenditures -30.40M, giving a free cash flow of 43.30M billion.
- Operating Cash Flow
- 58.10M
- Free Cash Flow
- 43.30M
- Free Cash Flow per Share
- 2.56
Dividends & Yields
Devyser Diagnostics AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.06%
- Earnings Yield
- 2.38%
Stock Price Statistics
- Beta
- 0.57
- 52-Week Price Change
- -42.64%
- 50-Day Moving Average
- 55.55
- 200-Day Moving Average
- 74.21
- Relative Strength Index (RSI)
- 57.04
- Average Volume (3m)
- 19.05K
Important Dates
Devyser Diagnostics AB upcoming earnings date is Feb 16, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Feb 16, 2027
- Ex-Dividend Date
- ―
Financial Position
Devyser Diagnostics AB as a current ratio of 2.88, with Debt / Equity ratio of 14.65%
- Current Ratio
- 2.88
- Quick Ratio
- 2.36
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.68
- Interest Coverage Ratio
- 0.78
Taxes
In the past 12 months, Devyser Diagnostics AB has paid 5.80M in taxes.
- Income Tax
- 5.80M
- Effective Tax Rate
- -2.23
Enterprise Valuation
Devyser Diagnostics AB EV to EBITDA ratio is 17.85, with an EV/FCF ratio of 23.58.
- EV to Sales
- 4.02
- EV to EBITDA
- 17.85
- EV to Free Cash Flow
- 23.58
- EV to Operating Cash Flow
- 17.57
Balance Sheet
Devyser Diagnostics AB has SEK 88.70M in cash and marketable securities with SEK 44.00M in debt, giving a net cash position of SEK 44.70M billion.
- Cash & Marketable Securities
- SEK 88.70M
- Total Debt
- SEK 44.00M
- Net Cash
- SEK 44.70M
- Net Cash Per Share
- SEK 2.65
- Tangible Book Value Per Share
- SEK 11.12
Margins
Gross margin is 80.06%, with operating margin of 11.04%, and net profit margin of 10.01%.
- Gross Margin
- 80.06%
- Operating Margin
- 11.04%
- Pretax Margin
- 12.10%
- Net Profit Margin
- 10.01%
- EBITDA Margin
- 22.55%
- EBIT Margin
- 11.79%
Analyst Forecast
The average price target for Devyser Diagnostics AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 4.49%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- ―
- AI Score
- 64

